"I was delighted to take part in a clinical trial as it has the potential to really help others in the future.”
A study of a test called ROCA for women who have a high risk of developing ovarian cancer (ALDO)
Please note - this trial is no longer recruiting patients. We hope to add results when they are available.
This study is for women who have changes (mutations) in the BRCA1 or BRCA2 gene. People who have BRCA1 or BRCA2 mutations have a high risk of developing certain cancers, including ovarian cancer.
More about this trial
- have children
- avoid early
- the results of the CA-125 test
- your age
- whether you have started the menopause
Who can enter
- have a change (mutation) in the BRCA1 or BRCA2 gene
- have at least one ovary and one fallopian tube
- are aged between 35 and 86 years old
- are pregnant or have been pregnant in the past 6 weeks
- have had ovarian cancer or doctors think you might have it
- have cancer or you have had treatment for cancer in the past 6 weeks
- tests your blood sample for the CA-125 protein
- checks your risk of developing ovarian cancer
You go to your GP or local hospital to have the blood tests every 4 months. This continues for up to a year.
You may need further tests if the ROCA test shows that you have a high risk of developing ovarian cancer. Your doctor can tell you which tests you need to have.
Having a blood test is very safe and the study team doesn’t think you will have any serious side effects from it. You may have some bruising at the site of injection.
How to join a clinical trial
Dr Adam Rosenthal
University College London Hospitals NHS Foundation Trust
UCLH Cancer Collaborative